Eikon Therapeutics, Inc. Common Stock (EIKN) — Financial Flexibility Index
Eikon Therapeutics, Inc. Common Stock (EIKN) has a Financial Flexibility Index of -0.21x as of June 2026. Free cash flow of $-64.71 Million (operating CF $-64.96 Million minus capex $251.00K) represents 0% of total liabilities ($313.07 Million). Check Eikon Therapeutics, Inc. Common Stock tangible equity quality to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Eikon Therapeutics, Inc. Common Stock Financial Flexibility Index (2023–2025)
Historical Financial Flexibility Index trend for Eikon Therapeutics, Inc. Common Stock across 3 annual periods. For the full cash flow conversion analysis, see Eikon Therapeutics, Inc. Common Stock cash flow conversion.
Annual Financial Flexibility Index for Eikon Therapeutics, Inc. Common Stock (2023–2025)
Year-by-year free cash flow to debt coverage for Eikon Therapeutics, Inc. Common Stock. Explore Eikon Therapeutics, Inc. Common Stock (EIKN) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.10x | $-141.78 Million | $-188.52 Million | $1.47 Billion | ▼ -104.6% |
| 2024 | -0.05x | $-50.00 Million | $-134.80 Million | $1.06 Billion | ▲ +74.9% |
| 2023 | -0.19x | $-162.34 Million | $-190.85 Million | $867.08 Million | — |